Atlas Trials

Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention

Clinical trial NCT03966066 · UNKNOWN

Trial details

NCT number
NCT03966066
Sponsor
Beijing Children's Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Bronchiectasis
Start date
2019-08-01
Primary completion
2020-07-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.